Danaher (DHR) Scheduled to Post Earnings on Tuesday

Danaher (NYSE:DHRGet Free Report) is set to release its earnings data before the market opens on Tuesday, April 23rd. Analysts expect Danaher to post earnings of $1.74 per share for the quarter. Persons interested in participating in the company’s earnings conference call can do so using this link.

Danaher (NYSE:DHRGet Free Report) last posted its quarterly earnings data on Tuesday, January 30th. The conglomerate reported $2.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.91 by $0.18. Danaher had a return on equity of 12.25% and a net margin of 17.26%. The company had revenue of $6.41 billion for the quarter, compared to the consensus estimate of $6.10 billion. During the same period in the previous year, the business earned $2.87 EPS. Danaher’s revenue for the quarter was down 10.2% compared to the same quarter last year. On average, analysts expect Danaher to post $8 EPS for the current fiscal year and $9 EPS for the next fiscal year.

Danaher Price Performance

Shares of NYSE DHR opened at $235.51 on Monday. Danaher has a twelve month low of $182.09 and a twelve month high of $259.00. The company has a current ratio of 1.68, a quick ratio of 1.37 and a debt-to-equity ratio of 0.31. The company has a market capitalization of $174.40 billion, a price-to-earnings ratio of 36.86, a price-to-earnings-growth ratio of 3.58 and a beta of 0.83. The business has a 50 day simple moving average of $248.94 and a 200-day simple moving average of $230.25.

Danaher Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 26th. Stockholders of record on Thursday, March 28th will be issued a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.46%. This is an increase from Danaher’s previous quarterly dividend of $0.24. The ex-dividend date is Wednesday, March 27th. Danaher’s payout ratio is 16.90%.

Insider Activity at Danaher

In related news, SVP Georgeann Couchara sold 2,622 shares of the firm’s stock in a transaction dated Tuesday, February 13th. The stock was sold at an average price of $242.67, for a total transaction of $636,280.74. Following the completion of the transaction, the senior vice president now owns 4,244 shares of the company’s stock, valued at $1,029,891.48. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other news, SVP Georgeann Couchara sold 2,622 shares of the company’s stock in a transaction on Tuesday, February 13th. The stock was sold at an average price of $242.67, for a total transaction of $636,280.74. Following the completion of the sale, the senior vice president now directly owns 4,244 shares of the company’s stock, valued at $1,029,891.48. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Walter G. Lohr sold 3,289 shares of the company’s stock in a transaction on Thursday, February 15th. The shares were sold at an average price of $251.15, for a total value of $826,032.35. Following the sale, the director now directly owns 14,129 shares of the company’s stock, valued at $3,548,498.35. The disclosure for this sale can be found here. Insiders sold 32,957 shares of company stock valued at $8,265,802 over the last 90 days. 11.10% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Danaher

Several hedge funds have recently bought and sold shares of the business. Hobbs Group Advisors LLC purchased a new stake in Danaher in the 4th quarter worth about $43,000. Sanibel Captiva Trust Company Inc. purchased a new stake in Danaher in the 4th quarter worth about $4,194,000. Oarsman Capital Inc. lifted its stake in Danaher by 54.0% in the 4th quarter. Oarsman Capital Inc. now owns 1,466 shares of the conglomerate’s stock worth $339,000 after acquiring an additional 514 shares in the last quarter. Harbour Investments Inc. increased its position in Danaher by 14.8% in the 4th quarter. Harbour Investments Inc. now owns 1,429 shares of the conglomerate’s stock worth $331,000 after purchasing an additional 184 shares during the last quarter. Finally, O Dell Group LLC acquired a new position in Danaher in the 4th quarter worth about $64,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on DHR shares. Barclays boosted their price target on Danaher from $240.00 to $260.00 and gave the company an “equal weight” rating in a report on Wednesday, April 10th. KeyCorp boosted their price target on Danaher from $260.00 to $290.00 and gave the company an “overweight” rating in a report on Thursday, February 1st. Raymond James upped their price objective on Danaher from $240.00 to $270.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 31st. HSBC upgraded Danaher from a “hold” rating to a “buy” rating and upped their price objective for the stock from $250.00 to $280.00 in a research note on Wednesday, April 17th. Finally, Royal Bank of Canada upped their price objective on Danaher from $254.00 to $282.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 31st. Six equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $268.27.

Get Our Latest Analysis on Danaher

Danaher Company Profile

(Get Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Featured Articles

Earnings History for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.